Pages that link to "Q77081886"

The following pages link to STUDIES OF INSULIN AND GROWTH HORMONE SECRETION IN HUMAN OBESITY (Q77081886):

Displaying 50 items.

• Fasting: the history, pathophysiology and complications (Q24536099) (← links)
• The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects (Q24628762) (← links)
• Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids (Q33961685) (← links)
• The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nerv (Q34081039) (← links)
• Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity (Q34193008) (← links)
• The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity (Q34271384) (← links)
• Metabolic clearance and production rates of human growth hormone (Q34283951) (← links)
• The role of carbohydrate and oral agents in the treatment of diabetes mellitus (Q34584973) (← links)
• Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency (Q34628461) (← links)
• Glucagon test for insulinoma: a chemical study in 25 cases (Q36534946) (← links)
• The Gordon Wilson lecture: growth hormone--1966. (Q36738768) (← links)
• Neonatal and maternal infections (Q36770062) (← links)
• Impaired growth hormone secretion in the adult population: relation to age and adiposity (Q36998642) (← links)
• Metabolic, endocrine, and drug-induced interference with pituitary function tests: A review (Q37579500) (← links)
• The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease (Q37620363) (← links)
• The effect of fasting, diet, and actinomycin D on insulin secretion in the rat (Q37710306) (← links)
• Progress report. Diagnosis of insulinoma (Q39894459) (← links)
• Teenage Obesity (Q39932885) (← links)
• What is diabetes mellitus? (Q39978814) (← links)
• Metabolic Studies of Human Obesity (Q39994916) (← links)
• New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus (Q40144631) (← links)
• Hormone-fuel interrelationships during fasting (Q40328913) (← links)
• Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity (Q40686495) (← links)
• Metabolic disturbances in obesity (Q41853092) (← links)
• Endocrine disturbances in childhood obesity: Growth-Hormone and cortisol response to insulin induced hypoglycemia (Q44273103) (← links)
• Dopaminergic stimulation of HGH in diabetes mellitus and in obesity (Q44335326) (← links)
• Insulin release in response to oral glucose in obesity: The effect of reduction of body weight (Q44445753) (← links)
• Acute symptomatic ketoacidosis following growth hormone administration in prolonged fasting (Q44523168) (← links)
• Influence of exogenous human growth hormone on the metabolism of fasting obese patients (Q45183377) (← links)
• Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women (Q45278902) (← links)
• Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus (Q47373927) (← links)
• Turnover rate of plasma FFA and rate of esterification of plasma FFA to plasma triglycerides in obese humans before and after weight reduction (Q47398073) (← links)
• Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. (Q47868374) (← links)
• Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function (Q50187841) (← links)
• Metabolic differences between males and females and between normal and obese subjects during total fast (Q50929401) (← links)
• The serum growth-hormone response to hypoglycemia in dwarfism (Q51203352) (← links)
• The gastro-entero-pancreatic hormone response to fasting in obesity (Q51653616) (← links)
• Impaired prolactin secretion in obese patients (Q51655332) (← links)
• Effect of prolonged fasting and of low-calorie diet on plasmatic levels of somatotropin and of insulin in obese subjects (Q51682324) (← links)
• Effect of weight loss and fasting on insulin secretion in obese subjects (Q51683151) (← links)
• Serum growth hormone and insulin in females without glucose intolerance (Q51685653) (← links)
• Enhanced postglucose hypophosphatemia during starvation therapy of obesity (Q51685900) (← links)
• Alcohol hypoglycemia. VII. Further studies on the refractoriness of obese subjects (Q51687529) (← links)
• Influence of norepinephrine, growth hormone and fasting on FFA mobilization and glucose metabolism in lean and obese subjects (Q51688630) (← links)
• Plasma insulin and growth hormone levels in obesity and diabetes (Q51691106) (← links)
• [Human growth hormone estimations in the differential diagnosis of chromophobe and eosinophil pituitary adenomas]. (Q53854180) (← links)
• Plasma growth hormone response to L-dopa in obese subjects (Q53923635) (← links)
• The effect of growth hormone on bioactive IGF in overweight/obese women. (Q54114968) (← links)
• Changes in plasma glucose, free fatty acids (FFA), cortisol, immunoreactive human growth hormone (IRHGH) and immunoreactive insulin (IRI) after tolbutamide-induced hypoglycemia in obese subjects. (Q54196717) (← links)
• Growth hormone response to propranolol and l-dopa in obese subjects (Q54345928) (← links)